Ginkgo Bioworks
DNA
DNA
312 hedge funds and large institutions have $312M invested in Ginkgo Bioworks in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 67 increasing their positions, 111 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
312
Holders Change
-29
Holders Change %
-8.5%
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
50
Increased
67
Reduced
111
Closed
72
Calls
$1.1M
Puts
$1.02M
Net Calls
+$75K
Net Calls Change
+$1.69M
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
$10.5M |
| 2 |
Two Sigma Investments
New York
|
$6.49M |
| 3 |
D.E. Shaw & Co
New York
|
$5.8M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$5.19M |
| 5 |
Legal & General Group
London,
United Kingdom
|
$8.86M |
